This contract expires in 116 days (Sep 30, 2026).
MCKESSON CORPORATION - FY26 Q4 MAT PHARMACEUTICALS TO BE SUPPLIED IN ACCORDANCE WITH THE TERMS AND CONDITIONS OF 36W79720D0001.
Key Details
Description
FY26 Q4 MAT PHARMACEUTICALS TO BE SUPPLIED IN ACCORDANCE WITH THE TERMS AND CONDITIONS OF 36W79720D0001.
Context & Analysis
On Feb 4, 2026, Department of Justice obligated $25,000 to MCKESSON CORPORATION for fy26 q4 mat pharmaceuticals to be supplied in accordance with the terms and conditions of 36w79720d0001.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in IRVING, TX. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Justice under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
MCKESSON NON-CONTROLLED DOS: NOV 1- CR MARCH 14, 2024
MCKESSON CORPORATION
$29.2M
MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025.
MCKESSON CORPORATION
$10.0M
PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 25 PROCUREMENT OF PHARMACEUTICALS ON THE PPV
MCKESSON CORPORATION
$5.3M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
MCKESSON STANDARD MEDICATION FY 2025
MCKESSON CORPORATION
$4.4M
Stay Updated
Get notified about new opportunities matching your interests.